Patents by Inventor Felipe Lombo Brugos

Felipe Lombo Brugos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298098
    Abstract: The present disclosure relates to halogenated fatty acid lactylates, in particular to chlorinated fatty acid lactylates. The halogenated fatty acid lactylates now disclosed have antimicrobial and/or antibiofilm activity towards healthcare associated microbial infections.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 22, 2022
    Inventors: Vitor Manuel DE OLIVEIRA E VASCONCELOS, Pedro Nuno COSTA LEÃO, Vítor Manuel CAPELA RAMOS, João Carlos PEREIRA MORAIS, Raquel CASTELO BRANCO, Flávio Luís DE OLIVEIRA, Mariana ALVES REIS, Sara María SOTO GONZÁLEZ, Yuly LÓPEZ CUBILLOS, Virginio CEPAS, Felipe LOMBÓ BRUGOS, Claudio J. VILLAR GRANJA, Ignacio Gutiérrez DEL RÍO MENÉNDEZ, Saúl REDONDO BLANCO, Fernando LÓPEZ ORTIZ, María José IGLESIAS VALDÉS-SOLÍS, Raquel María GONZÁLEZ SOENGAS, Liliana RODOLFI, Giacomo SAMPIETRO
  • Publication number: 20110207705
    Abstract: Oviedomycin derivatives, method for obtaining same and use thereof. This invention relates to oviedomycin derivatives obtained by fermentation of recombinant bacterial strains. The invention also relates to the methods used to obtain the recombinant strains and to produce the oviedomycin derivatives. The invention further relates to bacterial strains that can be used to produce oviedomycin derivatives. Finally, said oviedomycin derivatives are applicable in the field of the human health, specifically to produce drugs for the treatment of tumour diseases.
    Type: Application
    Filed: March 26, 2009
    Publication date: August 25, 2011
    Applicant: UNIVERSIDAD DE OVIEDO
    Inventors: Carmen Méndez Fernández, Felipe Lombó Brugos, Alfredo A. Fernández Braña, José Antonio Salas Fernández
  • Publication number: 20090130675
    Abstract: The invention relates to genes involved in the biosynthesis of thiocoraline and to the heterologous production of same. According to the invention, the cluster of genes responsible for the biosynthesis of thiocoraline was identified and cloned. Said cluster of genes can be used in the heterologous production of thiocoraline which has an antitumor and antibacterial activity.
    Type: Application
    Filed: August 1, 2006
    Publication date: May 21, 2009
    Applicant: PHARMA MAR, S.A.
    Inventors: Angelina Ramos Castro, Alfredo Fernandez Brana, Felipe Lombo Brugos, Carmen Mendez Fernandez, Jose Antonio Salas Fernandez, Ana Velasco Iglesias, Carmen Schleissner Sanchez